US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1195
  • -0.0006-0.50%
Close Oct 4 16:00 ET
  • 0.1193
  • -0.0002-0.17%
Post 19:58 ET
3.84MMarket Cap-1P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-37.20%2.53M
-28.05%3.54M
23.57%18.87M
4.77%5.38M
32.61%4.53M
12.93%4.03M
56.44%4.93M
5.39%15.27M
57.91%5.13M
-10.34%3.42M
Selling and administrative expenses
19.64%1.41M
-17.98%1.11M
-20.07%4.77M
-48.54%1.11M
-7.25%1.12M
-12.15%1.18M
7.80%1.36M
27.48%5.97M
140.15%2.15M
-1.97%1.21M
-General and administrative expense
19.64%1.41M
-17.98%1.11M
-20.07%4.77M
-48.54%1.11M
-7.25%1.12M
-12.15%1.18M
7.80%1.36M
27.48%5.97M
140.15%2.15M
-1.97%1.21M
Research and development costs
-60.76%1.12M
-31.88%2.43M
51.56%14.1M
43.25%4.27M
54.47%3.41M
28.10%2.85M
88.89%3.57M
-5.15%9.3M
26.61%2.98M
-14.36%2.21M
Operating profit
37.20%-2.53M
28.05%-3.54M
-23.57%-18.87M
-4.77%-5.38M
-32.61%-4.53M
-12.93%-4.03M
-56.44%-4.93M
-5.39%-15.27M
-57.91%-5.13M
10.34%-3.42M
Net non-operating interest income expense
-163.05%-2.62K
101.95%106
297.55%13.88K
278.24%4.12K
2,152.97%11.05K
357.73%4.15K
-111.85%-5.44K
24.32%-7.03K
-3.31%-2.31K
43.19%-538
Non-operating interest income
-76.35%1.85K
--6.73K
--27.69K
--7K
--12.88K
--7.8K
--0
--0
--0
--0
Non-operating interest expense
22.27%4.46K
21.87%6.63K
96.46%13.81K
24.61%2.88K
241.64%1.84K
126.57%3.65K
111.85%5.44K
-24.32%7.03K
3.31%2.31K
-43.19%538
Other net income (expense)
Income before tax
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
Income tax
Net income
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
Net income continuous Operations
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
Minority interest income
Net income attributable to the parent company
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
Basic earnings per share
87.04%-6.72
84.17%-20.5
10.87%-500
75.64%-43.2473
57.81%-54
61.15%-51.86
-6.15%-129.5
32.00%-561
1.39%-177.5
39.05%-128
Diluted earnings per share
87.04%-6.72
84.17%-20.5
10.87%-500
75.64%-43.2473
57.81%-54
61.15%-51.86
-6.15%-129.5
32.00%-561
1.39%-177.5
39.05%-128
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -37.20%2.53M-28.05%3.54M23.57%18.87M4.77%5.38M32.61%4.53M12.93%4.03M56.44%4.93M5.39%15.27M57.91%5.13M-10.34%3.42M
Selling and administrative expenses 19.64%1.41M-17.98%1.11M-20.07%4.77M-48.54%1.11M-7.25%1.12M-12.15%1.18M7.80%1.36M27.48%5.97M140.15%2.15M-1.97%1.21M
-General and administrative expense 19.64%1.41M-17.98%1.11M-20.07%4.77M-48.54%1.11M-7.25%1.12M-12.15%1.18M7.80%1.36M27.48%5.97M140.15%2.15M-1.97%1.21M
Research and development costs -60.76%1.12M-31.88%2.43M51.56%14.1M43.25%4.27M54.47%3.41M28.10%2.85M88.89%3.57M-5.15%9.3M26.61%2.98M-14.36%2.21M
Operating profit 37.20%-2.53M28.05%-3.54M-23.57%-18.87M-4.77%-5.38M-32.61%-4.53M-12.93%-4.03M-56.44%-4.93M-5.39%-15.27M-57.91%-5.13M10.34%-3.42M
Net non-operating interest income expense -163.05%-2.62K101.95%106297.55%13.88K278.24%4.12K2,152.97%11.05K357.73%4.15K-111.85%-5.44K24.32%-7.03K-3.31%-2.31K43.19%-538
Non-operating interest income -76.35%1.85K--6.73K--27.69K--7K--12.88K--7.8K--0--0--0--0
Non-operating interest expense 22.27%4.46K21.87%6.63K96.46%13.81K24.61%2.88K241.64%1.84K126.57%3.65K111.85%5.44K-24.32%7.03K3.31%2.31K-43.19%538
Other net income (expense)
Income before tax 37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M
Income tax
Net income 37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M
Net income continuous Operations 37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M
Minority interest income
Net income attributable to the parent company 37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M
Basic earnings per share 87.04%-6.7284.17%-20.510.87%-50075.64%-43.247357.81%-5461.15%-51.86-6.15%-129.532.00%-5611.39%-177.539.05%-128
Diluted earnings per share 87.04%-6.7284.17%-20.510.87%-50075.64%-43.247357.81%-5461.15%-51.86-6.15%-129.532.00%-5611.39%-177.539.05%-128
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data